- Our LinkedIn Page
- Our Twitter Feed
- Our Facebook Page
- Newsletter Subscribe to our monthly e-newsletter. Current Issue
- Our Flickr Feed
- Our YouTube Feed
Authors
- Abigail Hirsch
- Alan Eisenberg
- BIOtechNOW Editor
- Bruce Dale
- Celia Economides
- Colleen Lerro
- David Thomas
- George Goodno
- George MacDougall
- Jason Corum
- Jeff Joseph
- Jim Greenwood
- Karen Batra
- Kelly Cappio
- Lila Feisee
- Matt Carr
- Nathan Schock
- Paul Winters
- Paulina Ibarra
- Robbi Lycett
- Roy Zwahlen
- Sarah Sneeringer
- Sondra Behan
- Stephanie Fischer
- Stephen Marmaras
- Timothy Coetzee
- Tracy Cooley
Tags
Food agriculture Partnering Climate Change One-on-One's biotechnology Food and Fuel indirect land use change Biofuel Technology Plant biotechnology BIO Investor Forum ethanol global food crisis Animal biotechnology renewable fuel standard BIO Greenhouse Gas Emission greenhouse gas emissions Benefits of biotech cropsOne-on-One Partnering
Archive
- February 2012 (1)
- December 2011 (2)
- October 2011 (3)
- September 2011 (2)
- August 2011 (1)
- July 2011 (1)
- June 2011 (4)
- May 2011 (5)
- April 2011 (5)
- March 2011 (2)
- December 2010 (1)
- September 2010 (1)
- April 2010 (5)
- March 2010 (6)
- February 2010 (1)
- January 2010 (2)
Category Archives: What would George do?
BIO CEO Company Snapshot: ImmunoGen, Inc.
In the latest Company Snapshot for the 2012 BIO CEO & Investor Conference in New York City, we’re profiling ImmunoGen, Inc. which will be presenting at the event. We spoke with ImmunoGen, Inc. CEO Daniel Junius and he outlined his organization’s priorities and challenges as well as how his company differentiates themselves from the competition. Company Snapshot What are the short-term and long-term priorities for your company? Our highest priority today is building and advancing our pipeline Read More >
BIO CEO Company Snapshot: NuPathe Inc.
The Company Snapshots have returned for our next One-on-One Partnering event, the BIO CEO & Investor Conference, taking place in New York City this February. The companies that will be profiled in these snapshots will all be presenting at the event, and we hope this provides the opportunity to learn more about them, and catch up on what’s new. For our first Snapshot for the BIO CEO event, we’ve spoken with NuPathe Inc. about their Read More >
Start 2012 with BIO – in Osaka!
With BIO’s Fall events behind us, the team here quickly shifted focus to 2012! On January 31st, the BIO Asia International Conference will commence its ninth year! What’s something new about the conference? It’s moved! Originally, BIO Asia was hosted in Tokyo, but the event has relocated for the first time and will now be held in Osaka, Japan. We’re very excited about being in this city, which is Japan’s third largest, and is well-known Read More >
BIO Investor Forum Company Snapshot: Protagonist Therapeutics
In our final Investor Forum Company Snapshot, we’ve profiled one of the Discovery Companies who will be presenting at the event. Protagonist Therapeutics shares their take on funding challenges and upcoming priorities, plus interesting facts about their company. Don’t miss their presentation first thing Tuesday morning! Company Snapshot What are the short-term and long-term priorities for your company? Protagonist is a peptide therapeutics based technology platform company. Short term priority: Secure a second collaboration and Read More >
A What Would George Do? Tribute
For those of you who have been attending BIO events over the past few years, you’ve not only come to know the One-on-One Partnering System, but BIO staff as well. In particular, our Partnering Guru George MacDougall, – the very person our blog is named after! Recently, George accepted a position at another DC non-profit and is moving on from BIO. In honor of all his hard work, exceptional customer service, and contributions to the Read More >
